Biblio

Found 9 results
Filters: Keyword is Cognition Disorders  [Clear All Filters]
2015
Bower JE, Ganz PA.  2015.  Symptoms: Fatigue and Cognitive Dysfunction.. Adv Exp Med Biol. 862:53-75.
2014
Ganz PA, Petersen L, Castellon SA, Bower JE, Silverman DHS, Cole SW, Irwin MR, Belin TR.  2014.  Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.. J Clin Oncol. 32(31):3559-67.
2013
Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Mallam S, Cheng I, Ahn R, Breen EC, Irwin MR et al..  2013.  The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.. Brain Imaging Behav. 7(4):511-23.
Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DHS, Geist C, Breen EC, Irwin MR, Cole SW.  2013.  Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun. 30 Suppl:S99-108.
2012
Colby JB, Smith L, O'Connor MJ, Bookheimer SY, Van Horn JD, Sowell ER.  2012.  White matter microstructural alterations in children with prenatal methamphetamine/polydrug exposure.. Psychiatry Res. 204(2-3):140-8.
2008
Bower JE.  2008.  Behavioral symptoms in patients with breast cancer and survivors.. J Clin Oncol. 26(5):768-77.
Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR.  2008.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.. J Clin Oncol. 26(6):971-82.
2007
Deadwyler SA, Porrino L, Siegel JM, Hampson RE.  2007.  Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.. J Neurosci. 27(52):14239-47.
2004
Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA.  2004.  Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.. J Clin Exp Neuropsychol. 26(7):955-69.